PapersPMID:35447899
Fucoxanthin Attenuates Free Fatty Acid-Induced Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism/Oxidative Stress/Inflammation via the AMPK/Nrf2/TLR4 Signaling Pathway.
What moved
1 findingHow to read these marks →- Inhibits TLR4
very limited
“The expression of TLR4 and its downstream proteins myeloid differentiation factor 88 (MyD88), p-IκBα, and p-NF-κBp65 was significantly upregulated in the FFA group, and was significantly inhibited by treatment with fucoxanthin.”
- Study
- in vitro · not in humans
- Population
- Human Chang liver cell line, FFA-induced NAFLD cell model, fucoxanthin group
Study record
- Design
- in vitro
- Species
- cells
- Population
- Human Chang liver cell line, free-fatty-acid (oleate/palmitate 2:1, 1 mM, 24 h)-induced nonalcoholic fatty liver disease (NAFLD) cell model
- Participants
- not reported
- Comparator
- placebo / within arm
- Duration
- 1 day
- Endpoints measured
- 8